<center>Future Tech investment articles generated using Ai technology </center>

Showing posts with label gene editing. Show all posts
Showing posts with label gene editing. Show all posts
Tuesday, November 17, 2026

An Alternative to an Uncertain AI Trade - medicine and, in particular, Genetics

›
  Investment Note: Gene editing in focus Why I like BEAM, CRSP and NTLA  The Next Medical Revolution — and an Alternative to an Uncertain AI...
Tuesday, June 25, 2024

Going forward, how viable is Beam Therapeutics in the BioTech market?

›
  Fr: ChatGPT Beam Therapeutics appears to be a viable biotechnology company, with several strengths that contribute to its potential: Finan...
Thursday, June 20, 2024

Illumina's strong market position in the genomics and life sciences sectors, positive return on equity, recent insider buying and Ai applications signal confidence in its future​

›
 Illumina Inc. (NASDAQ: ILMN), has several positive indicators for the company's prospects going forward. Analyst Ratings and Price Targ...
1 comment:
Friday, May 10, 2024

Can two small caps become the kings of synthetic biology? Only time will tell!

›
  Both Twist Biosciences and Ginkgo Bioworks are prominent players  in the field of   Synthetic biology , but they have different focus...
›
Home
View web version
Powered by Blogger.